SLUG‐related partial epithelial‐to‐mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival
Henrik Schinke(Roche Pharma AG (Germany)), Olivier Gires(LMU Klinikum)
Cited by 28
Related Papers
EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers
|PLoS Biology|2018|97
High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma
|Scientific Reports|2018|44
CD133 induces tumour-initiating properties in HEK293 cells
|Tumor Biology|2012|23
Multi-omics analysis to uncover the molecular basis of tumor budding in head and neck squamous cell carcinoma
|npj Precision Oncology|2025|6